Skip to content

Nasal oscillation device targeting nasal congestion

A nasal airflow oscillation device targeting relieve nasal congestion

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623001307695
Enrollment
20
Registered
2023-12-15
Start date
2024-01-08
Completion date
2024-02-01
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Upper respiratory tract complaints are common in the general population. A safe, non-pharmacologic treatment would be an attractive option for many patients either as an alternative to existing therapies, or as a complementary therapy. This study assesses the acceptability, safety and possible efficacy of a nasal airflow oscillation device in a group of people suffering chronic nasal congestion.

Interventions

A small nasal airflow oscillation device that plugs into the nose to create nasal pressure oscillations at 130 Hz has been developed. The purpose of this study is to assess the acceptability, safety, and possible efficacy of this small nasal airflow oscillation device in subjects suffering nasal congestion. The subject will be asked to wear the device in their nose on one occasion for 20 minutes. Participants will be asked to sit down quietly for twenty minutes. The participants will be monitore

A small nasal airflow oscillation device that plugs into the nose to create nasal pressure oscillations at 130 Hz has been developed. The purpose of this study is to assess the acceptability, safety, and possible efficacy of this small nasal airflow oscillation device in subjects suffering nasal congestion. The subject will be asked to wear the device in their nose on one occasion for 20 minutes. Participants will be asked to sit down quietly for twenty minutes. The participants will be monitored by research staff on a regular basis.

Sponsors

Jim Bartley
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Adults aged from 18-80 years with a history of chronic nasal congestion for more than one year

Exclusion criteria

Cigarette smoking, a fixed structural cause of nasal congestion (moderate or severe septal deviation), moderate or severe nasal valve collapse, Grade 2-4 polyps, recent upper respiratory illness, nasal decongestant use within the last week, nasal crusting or ulceration on rhinoscopy, a history of severe nose bleeding within the last 3 months, anticoagulant use, known pregnancy, allergic sensitivity to silicone or any other component of device, and inability to read and understand English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 6, 2026